anti cd8 apc cy7 mabs Search Results


95
ATCC rat igg anti mouse cd8 mabs
Rat Igg Anti Mouse Cd8 Mabs, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rat igg anti mouse cd8 mabs/product/ATCC
Average 95 stars, based on 1 article reviews
rat igg anti mouse cd8 mabs - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

95
Miltenyi Biotec anti cd8 mabs
Anti Cd8 Mabs, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd8 mabs/product/Miltenyi Biotec
Average 95 stars, based on 1 article reviews
anti cd8 mabs - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

90
Becton Dickinson cy-chrome conjugated anti-cd8 mab
Cy Chrome Conjugated Anti Cd8 Mab, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cy-chrome conjugated anti-cd8 mab/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
cy-chrome conjugated anti-cd8 mab - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Agilent technologies mouse anti-human cd8 monoclonal antibody
Mouse Anti Human Cd8 Monoclonal Antibody, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti-human cd8 monoclonal antibody/product/Agilent technologies
Average 90 stars, based on 1 article reviews
mouse anti-human cd8 monoclonal antibody - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

95
Bio-Rad anti bovine cd8 mab
Anti Bovine Cd8 Mab, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti bovine cd8 mab/product/Bio-Rad
Average 95 stars, based on 1 article reviews
anti bovine cd8 mab - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

86
Danaher Inc mouse monoclonal anti cd8 ab
Mouse Monoclonal Anti Cd8 Ab, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal anti cd8 ab/product/Danaher Inc
Average 86 stars, based on 1 article reviews
mouse monoclonal anti cd8 ab - by Bioz Stars, 2026-04
86/100 stars
  Buy from Supplier

90
Servicebio Inc anti-cd8 alpha mouse mab
Anti Cd8 Alpha Mouse Mab, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-cd8 alpha mouse mab/product/Servicebio Inc
Average 90 stars, based on 1 article reviews
anti-cd8 alpha mouse mab - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Becton Dickinson anti-cd8 mab (53-6.7
Anti Cd8 Mab (53 6.7, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-cd8 mab (53-6.7/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
anti-cd8 mab (53-6.7 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology rat anti-mouse cd8 monoclonal
Rat Anti Mouse Cd8 Monoclonal, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rat anti-mouse cd8 monoclonal/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
rat anti-mouse cd8 monoclonal - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Millipore monoclonal mouse anti-cd8
Monoclonal Mouse Anti Cd8, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal mouse anti-cd8/product/Millipore
Average 90 stars, based on 1 article reviews
monoclonal mouse anti-cd8 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc anti cd8
Proliferating F4/80 + macrophages were reduced in Panc02 and KPC mouse models after clodronate liposomes treatment. ( A , B ) Representative immunofluorescence images of Ki-67 and F4/80 staining in Panc02 or KPC tumors and quantitation of Ki-67 and F4/80 immunofluorescence staining. ( C ) Analysis of BrdU + macrophages in Panc02 and KPC tumor tissues. The animals were injected with BrdU at 12 h and 24 h before sacrifice. ( D , E ) Staining of <t>CD8</t> + T and Foxp3 + T cells in Panc02 or KPC tumors with or without clodronate liposomes treatment. Data are shown as the mean ± SEM. Statistical analyses were carried out by Student’s t test. *: p ≤ 0.05, **: p ≤ 0.01.
Anti Cd8, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd8/product/Cell Signaling Technology Inc
Average 97 stars, based on 1 article reviews
anti cd8 - by Bioz Stars, 2026-04
97/100 stars
  Buy from Supplier

90
Becton Dickinson anti-rat cd3 mabs
Proliferating F4/80 + macrophages were reduced in Panc02 and KPC mouse models after clodronate liposomes treatment. ( A , B ) Representative immunofluorescence images of Ki-67 and F4/80 staining in Panc02 or KPC tumors and quantitation of Ki-67 and F4/80 immunofluorescence staining. ( C ) Analysis of BrdU + macrophages in Panc02 and KPC tumor tissues. The animals were injected with BrdU at 12 h and 24 h before sacrifice. ( D , E ) Staining of <t>CD8</t> + T and Foxp3 + T cells in Panc02 or KPC tumors with or without clodronate liposomes treatment. Data are shown as the mean ± SEM. Statistical analyses were carried out by Student’s t test. *: p ≤ 0.05, **: p ≤ 0.01.
Anti Rat Cd3 Mabs, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-rat cd3 mabs/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
anti-rat cd3 mabs - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Proliferating F4/80 + macrophages were reduced in Panc02 and KPC mouse models after clodronate liposomes treatment. ( A , B ) Representative immunofluorescence images of Ki-67 and F4/80 staining in Panc02 or KPC tumors and quantitation of Ki-67 and F4/80 immunofluorescence staining. ( C ) Analysis of BrdU + macrophages in Panc02 and KPC tumor tissues. The animals were injected with BrdU at 12 h and 24 h before sacrifice. ( D , E ) Staining of CD8 + T and Foxp3 + T cells in Panc02 or KPC tumors with or without clodronate liposomes treatment. Data are shown as the mean ± SEM. Statistical analyses were carried out by Student’s t test. *: p ≤ 0.05, **: p ≤ 0.01.

Journal: Cancers

Article Title: Targeting Proliferating Tumor-Infiltrating Macrophages Facilitates Spatial Redistribution of CD8 + T Cells in Pancreatic Cancer

doi: 10.3390/cancers14061474

Figure Lengend Snippet: Proliferating F4/80 + macrophages were reduced in Panc02 and KPC mouse models after clodronate liposomes treatment. ( A , B ) Representative immunofluorescence images of Ki-67 and F4/80 staining in Panc02 or KPC tumors and quantitation of Ki-67 and F4/80 immunofluorescence staining. ( C ) Analysis of BrdU + macrophages in Panc02 and KPC tumor tissues. The animals were injected with BrdU at 12 h and 24 h before sacrifice. ( D , E ) Staining of CD8 + T and Foxp3 + T cells in Panc02 or KPC tumors with or without clodronate liposomes treatment. Data are shown as the mean ± SEM. Statistical analyses were carried out by Student’s t test. *: p ≤ 0.05, **: p ≤ 0.01.

Article Snippet: The Abs used were purchased from Cell Signaling Technology: anti-CD68 (D4B9C), anti-CD86 (E2G8P), anti-CD163 (D6U1J), anti-pan-keratin (C11), anti-F4/80 (D2S9R), anti-Ki-67 (D3B5), and anti-CD8 (D4W2Z); an Opal 4-color Manual IHC Kit (PerkinElmer, Spokane, WA, USA) was used for mIHC.

Techniques: Immunofluorescence, Staining, Quantitation Assay, Injection

The antitumor response induced by targeting macrophages is CD8 + T-cell-dependent. ( A ) Representative flow cytometric analysis of CD8 + T cells to confirm depletion was carried out. ( B , C ) Mice were treated with 200 μL (intraperitoneal injection) of control liposomes or clodronate liposomes on days −1 and 0 and every 3 days afterward, and/or with isotype control or anti-CD8 antibodies on days −1, 0, 5, 10, and 15 ( n = 5 mice/group). Left: tumor growth curves showing the volumes of subcutaneously implanted tumors in mice ( n = 5 per group) treated with control liposomes or clodronate liposomes. Right: final tumor weights. ( D , E ) Flow cytometric analysis of tumor-infiltrating CD8 + T cells ( D ) and Foxp3 + Tregs ( E ). Each data point represents a mouse. Data are shown as the mean ± SEM. Statistical analyses were performed by one-way ANOVA with Tukey’s correction for multiple comparisons. *: p ≤ 0.05, **: p ≤ 0.01, ***: p ≤ 0.001.

Journal: Cancers

Article Title: Targeting Proliferating Tumor-Infiltrating Macrophages Facilitates Spatial Redistribution of CD8 + T Cells in Pancreatic Cancer

doi: 10.3390/cancers14061474

Figure Lengend Snippet: The antitumor response induced by targeting macrophages is CD8 + T-cell-dependent. ( A ) Representative flow cytometric analysis of CD8 + T cells to confirm depletion was carried out. ( B , C ) Mice were treated with 200 μL (intraperitoneal injection) of control liposomes or clodronate liposomes on days −1 and 0 and every 3 days afterward, and/or with isotype control or anti-CD8 antibodies on days −1, 0, 5, 10, and 15 ( n = 5 mice/group). Left: tumor growth curves showing the volumes of subcutaneously implanted tumors in mice ( n = 5 per group) treated with control liposomes or clodronate liposomes. Right: final tumor weights. ( D , E ) Flow cytometric analysis of tumor-infiltrating CD8 + T cells ( D ) and Foxp3 + Tregs ( E ). Each data point represents a mouse. Data are shown as the mean ± SEM. Statistical analyses were performed by one-way ANOVA with Tukey’s correction for multiple comparisons. *: p ≤ 0.05, **: p ≤ 0.01, ***: p ≤ 0.001.

Article Snippet: The Abs used were purchased from Cell Signaling Technology: anti-CD68 (D4B9C), anti-CD86 (E2G8P), anti-CD163 (D6U1J), anti-pan-keratin (C11), anti-F4/80 (D2S9R), anti-Ki-67 (D3B5), and anti-CD8 (D4W2Z); an Opal 4-color Manual IHC Kit (PerkinElmer, Spokane, WA, USA) was used for mIHC.

Techniques: Injection

Targeting macrophages promoted CD8 + T cell spatial redistribution in tumors. Panc02 and KPC murine pancreatic tumor cells were subcutaneously injected into C57BL/6 mice, and the effects of treatment with control liposomes or clodronate liposomes on intratumoral T cell infiltration and spatial redistribution after macrophage targeting were evaluated. ( A , B ) Representative images of the edge (periphery) and center (core) of the tumor sections after anti-CD8 immunostaining are shown. For each tumor, the numbers of CD8 + T cells at the edge of the tumor (≤500 µm from the edge of the tumor) and the tumor center (>500 μm from the edge of the tumor) were quantified. The distance between the nuclear centers of a PanCK + tumor cells and their nearest CD8 + T cells was calculated for each PanCK + cell identified within the tumor center. ( C , D ) The average distances of CD8 + T cells to tumor cells in all tumor samples were calculated. ( C , D ) ( right ) The distribution of CD8 + T cells within 30 μm from tumor cells. Each group contained five mice, corresponding to the five points in the bar graph. We analyzed at least five views for each point and calculated the average density of cells at the center and edge to represent each slide. ( E ) Representative flow cytometric analysis of IFN-γ + CD8 + cells in CD8 + T cells and a statistical graph are shown. Data are shown as the mean ± SEM. Statistical analyses were carried out by Student’s t test. *: p ≤ 0.05, **: p ≤ 0.01, ***: p ≤ 0.001, ns: not significant ( p > 0.05).

Journal: Cancers

Article Title: Targeting Proliferating Tumor-Infiltrating Macrophages Facilitates Spatial Redistribution of CD8 + T Cells in Pancreatic Cancer

doi: 10.3390/cancers14061474

Figure Lengend Snippet: Targeting macrophages promoted CD8 + T cell spatial redistribution in tumors. Panc02 and KPC murine pancreatic tumor cells were subcutaneously injected into C57BL/6 mice, and the effects of treatment with control liposomes or clodronate liposomes on intratumoral T cell infiltration and spatial redistribution after macrophage targeting were evaluated. ( A , B ) Representative images of the edge (periphery) and center (core) of the tumor sections after anti-CD8 immunostaining are shown. For each tumor, the numbers of CD8 + T cells at the edge of the tumor (≤500 µm from the edge of the tumor) and the tumor center (>500 μm from the edge of the tumor) were quantified. The distance between the nuclear centers of a PanCK + tumor cells and their nearest CD8 + T cells was calculated for each PanCK + cell identified within the tumor center. ( C , D ) The average distances of CD8 + T cells to tumor cells in all tumor samples were calculated. ( C , D ) ( right ) The distribution of CD8 + T cells within 30 μm from tumor cells. Each group contained five mice, corresponding to the five points in the bar graph. We analyzed at least five views for each point and calculated the average density of cells at the center and edge to represent each slide. ( E ) Representative flow cytometric analysis of IFN-γ + CD8 + cells in CD8 + T cells and a statistical graph are shown. Data are shown as the mean ± SEM. Statistical analyses were carried out by Student’s t test. *: p ≤ 0.05, **: p ≤ 0.01, ***: p ≤ 0.001, ns: not significant ( p > 0.05).

Article Snippet: The Abs used were purchased from Cell Signaling Technology: anti-CD68 (D4B9C), anti-CD86 (E2G8P), anti-CD163 (D6U1J), anti-pan-keratin (C11), anti-F4/80 (D2S9R), anti-Ki-67 (D3B5), and anti-CD8 (D4W2Z); an Opal 4-color Manual IHC Kit (PerkinElmer, Spokane, WA, USA) was used for mIHC.

Techniques: Injection, Immunostaining